SCLERODERMA, SYSTEMIC
Clinical trials for SCLERODERMA, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA, SYSTEMIC trials appear
Sign up with your email to follow new studies for SCLERODERMA, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to halt scarring in scleroderma lungs
Disease control Recruiting nowThis study is testing whether adding the drug belimumab to standard treatment helps adults with scleroderma who have developed scarring in their lungs. It will measure if the drug can slow the decline in lung function and also improve skin thickening and symptoms like fatigue ove…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: PHASE2, PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC
-
Can a new exercise approach ease the burden of scleroderma?
Symptom relief Recruiting nowThis study is testing a special exercise program called BETY, designed for people with scleroderma. The program aims to improve physical function, strength, and overall well-being by combining physical activity with psychological and social support. Researchers will enroll 48 chi…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
New hope for healing painful finger sores in scleroderma patients
Symptom relief Recruiting nowThis study is testing whether a medication called diosmin can help heal painful open sores on the fingers of people with scleroderma. About 45 participants will be randomly assigned to receive either diosmin or a placebo pill for 8 weeks. Researchers will track how well the sores…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: Primus Pharmaceuticals • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Hair scan may reveal hidden organ damage in scleroderma
Knowledge-focused Recruiting nowThis study investigates whether a simple, non-invasive hair and scalp examination called trichoscopy can help predict which scleroderma patients might develop serious organ complications. Researchers will compare scalp images from 200 scleroderma patients with those from healthy …
Matched conditions: SCLERODERMA, SYSTEMIC
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists hunt for clues in blood and skin to unlock scleroderma mysteries
Knowledge-focused Recruiting nowThis study aims to discover what causes systemic sclerosis (scleroderma) and find markers that can predict how the disease will progress or respond to treatment. Researchers will collect and analyze blood, skin, and DNA samples from 150 patients in Sweden. The goal is to identify…
Matched conditions: SCLERODERMA, SYSTEMIC
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC